These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11224935)

  • 1. Multidimensional aspects of pain in HIV-infected individuals.
    Del Borgo C; Izzi I; Chiarotti F; Del Forno A; Moscati AM; Cornacchione E; Fantoni M
    AIDS Patient Care STDS; 2001 Feb; 15(2):95-102. PubMed ID: 11224935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.
    Liang SH; Lo YC; Lin HH; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2008 Jun; 41(3):200-8. PubMed ID: 18629414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
    Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
    J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis G virus RNA in human immunodeficiency virus type 1-positive intravenous drug users.
    Zehender G; De Maddalena C; Bosisio AB; Gianotto M; Santambrogio S; Moroni M; Galli M
    J Hum Virol; 1998; 1(2):96-100. PubMed ID: 10195238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of human herpesvirus type 8 and parvovirus B19 infections and their association with HIV-1 among men who have sex with men and injection drug users in Taiwan.
    Lee YM; Chuang SY; Wang SF; Lin YT; Chen YM
    J Microbiol Immunol Infect; 2014 Jun; 47(3):233-8. PubMed ID: 23465711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentre study on the prevalence of symptoms and symptomatic treatment in HIV infection. Central Italy PRESINT Group.
    Fantoni M; Ricci F; Del Borgo C; Izzi I; Damiano F; Moscati AM; Marasca G; Bevilacqua N; Del Forno A
    J Palliat Care; 1997; 13(2):9-13. PubMed ID: 9231582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
    Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
    Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain among ambulatory HIV/AIDS patients: multicenter study of prevalence, intensity, associated factors, and effect.
    Namisango E; Harding R; Atuhaire L; Ddungu H; Katabira E; Muwanika FR; Powell RA
    J Pain; 2012 Jul; 13(7):704-13. PubMed ID: 22748803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
    J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection.
    Youle M; Osio M;
    HIV Med; 2007 May; 8(4):241-50. PubMed ID: 17461852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain management in HIV and AIDS.
    Newshan G
    GMHC Treat Issues; 1995 Apr; 9(4):5, 10-2. PubMed ID: 11362366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection.
    Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Barrio E
    Am J Gastroenterol; 2000 May; 95(5):1316-22. PubMed ID: 10811346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in human immunodeficiency virus infection among drug users in a detoxification unit.
    Muga R; Sanvisens A; Egea JM; Tor J; Rey-Joly C
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S404-9. PubMed ID: 14648455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIV-infected patients.
    De Rosa FG; Cicalini S; Canta F; Audagnotto S; Cecchi E; Di Perri G
    Infection; 2007 Jun; 35(3):154-60. PubMed ID: 17565456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain in pediatric human immunodeficiency virus infection: incidence and characteristics in a single-institution pilot study.
    Hirschfeld S; Moss H; Dragisic K; Smith W; Pizzo PA
    Pediatrics; 1996 Sep; 98(3 Pt 1):449-52. PubMed ID: 8784372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and treatment of pain in adults admitted to Italian hospitals.
    Visentin M; Zanolin E; Trentin L; Sartori S; de Marco R
    Eur J Pain; 2005 Feb; 9(1):61-7. PubMed ID: 15629876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.
    Larsen MV; Omland LH; Gerstoft J; Røge BT; Larsen CS; Pedersen G; Obel N; Kronborg G
    Scand J Infect Dis; 2010 Dec; 42(11-12):917-23. PubMed ID: 20840000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.
    Muga R; Langohr K; Tor J; Sanvisens A; Serra I; Rey-Joly C; Muñoz A
    Clin Infect Dis; 2007 Aug; 45(3):370-6. PubMed ID: 17599317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program.
    Lin HH; Lee SS; Yu ML; Chang TT; Su CW; Hu BS; Chen YS; Huang CK; Lai CH; Lin JN; Wu JC
    Hepatology; 2015 Jun; 61(6):1870-9. PubMed ID: 25677884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.